Adverse drug reaction and impact of it of pulmonary tuberculosis treatment.

Adverse drug reaction and impact of it of pulmonary tuberculosis treatment. - Adverse drug reaction and impact of it of pulmonary tuberculosis treatment.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043605

Enrollment

120

Registered

2021-03-15

Start date

2021-03-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary tuberculosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who started pulmonary tuberculosis treatment at our hospital from April 2018 to March 2020.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
The difference of the incidence of adverse drug reaction that requires discontinuation or change of medication (dADR) by age among patients aged 50 or older.	—

Countries

Japan

Contacts

Public ContactTakahiro Kaki

National Hospital Organization Wakayama Hospital Department of Respiratory Medicine

tk-3155kaki.xd7@nifty.com0738-22-3256

Outcome results